Elizabeth S DeWitt1, Stephanie F Chandler1, Robyn J Hylind1, Virginie Beausejour Ladouceur1, Elizabeth D Blume2, Christina VanderPluym2, Andrew J Powell2, Francis Fynn-Thompson3, Amy E Roberts2, Stephen P Sanders4, Vassilios Bezzerides1, Neal K Lakdawala5, Calum A MacRae5, Dominic J Abrams6. 1. Inherited Cardiac Arrhythmia Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. 2. Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. 3. Department of Cardiovascular Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. 4. Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. 5. Cardiovascular Genetics Program, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 6. Inherited Cardiac Arrhythmia Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: dominic.abrams@cardio.chboston.org.
Abstract
BACKGROUND: Arrhythmogenic cardiomyopathy (ACM) is a variably penetrant disease increasingly identified in young patients. OBJECTIVES: This study sought to describe the diverse phenotype, genotype, and outcomes in pediatric and adolescent patients. METHODS: Records from 1999 to 2016 were reviewed for individuals age <21 years with a consistent personal or family history. Patients were categorized by right ventricular (RV), left dominant (LD), or biventricular subtypes using 2010 Task Force Criteria or proposed features of LD disease, encompassing electrocardiographic, structural, histological, and arrhythmic characteristics. Genetic variants classified as pathogenic and/or likely pathogenic by 2015 American College of Medical Genetics and Genomics criteria in recognized disease-associated genes were included. RESULTS: Manifest disease was evident in 32 patients (age 15.1 ± 3.8 years), of whom 22 were probands, including 16 RV, 7 LD, and 9 biventricular ACM. Nondiagnostic features were seen in 5 of 15 family members. RV disease was associated with cardiac arrest and ventricular tachycardia (p = 0.02) and prevalence of PKP2 variants (p < 0.01), whereas biventricular disease was associated with a younger age of onset (p = 0.02). LD ACM was associated with variants in DSP and LMNA, and biventricular ACM with more a diverse etiology in desmosomal genes. Cardiac arrest was observed in 5 probands (age 15.3 ± 1.9 years) and ventricular tachycardia in 10 (age 16.6 ± 2.7 years), 6 probands, and 4 family members. Features suggestive of myocardial inflammation were seen in 6 patients, with ventricular tachycardia and/or cardiac arrest in 3 patients. Cardiac transplantation was performed in 10 patients. There were no deaths. In RV and biventricular disease, electrocardiographic preceded imaging features, whereas the reverse was seen in LD disease. CONCLUSIONS: ACM in the young has highly varied phenotypic expression incorporating life-threatening arrhythmia, heart failure, and myocardial inflammation. Increased awareness of early onset, aggressive disease has important implications for patient management and familial screening.
BACKGROUND:Arrhythmogenic cardiomyopathy (ACM) is a variably penetrant disease increasingly identified in young patients. OBJECTIVES: This study sought to describe the diverse phenotype, genotype, and outcomes in pediatric and adolescent patients. METHODS: Records from 1999 to 2016 were reviewed for individuals age <21 years with a consistent personal or family history. Patients were categorized by right ventricular (RV), left dominant (LD), or biventricular subtypes using 2010 Task Force Criteria or proposed features of LD disease, encompassing electrocardiographic, structural, histological, and arrhythmic characteristics. Genetic variants classified as pathogenic and/or likely pathogenic by 2015 American College of Medical Genetics and Genomics criteria in recognized disease-associated genes were included. RESULTS: Manifest disease was evident in 32 patients (age 15.1 ± 3.8 years), of whom 22 were probands, including 16 RV, 7 LD, and 9 biventricular ACM. Nondiagnostic features were seen in 5 of 15 family members. RV disease was associated with cardiac arrest and ventricular tachycardia (p = 0.02) and prevalence of PKP2 variants (p < 0.01), whereas biventricular disease was associated with a younger age of onset (p = 0.02). LD ACM was associated with variants in DSP and LMNA, and biventricular ACM with more a diverse etiology in desmosomal genes. Cardiac arrest was observed in 5 probands (age 15.3 ± 1.9 years) and ventricular tachycardia in 10 (age 16.6 ± 2.7 years), 6 probands, and 4 family members. Features suggestive of myocardial inflammation were seen in 6 patients, with ventricular tachycardia and/or cardiac arrest in 3 patients. Cardiac transplantation was performed in 10 patients. There were no deaths. In RV and biventricular disease, electrocardiographic preceded imaging features, whereas the reverse was seen in LD disease. CONCLUSIONS: ACM in the young has highly varied phenotypic expression incorporating life-threatening arrhythmia, heart failure, and myocardial inflammation. Increased awareness of early onset, aggressive disease has important implications for patient management and familial screening.
Authors: Frank I Marcus; William J McKenna; Duane Sherrill; Cristina Basso; Barbara Bauce; David A Bluemke; Hugh Calkins; Domenico Corrado; Moniek G P J Cox; James P Daubert; Guy Fontaine; Kathleen Gear; Richard Hauer; Andrea Nava; Michael H Picard; Nikos Protonotarios; Jeffrey E Saffitz; Danita M Yoerger Sanborn; Jonathan S Steinberg; Harikrishna Tandri; Gaetano Thiene; Jeffrey A Towbin; Adalena Tsatsopoulou; Thomas Wichter; Wojciech Zareba Journal: Circulation Date: 2010-02-19 Impact factor: 29.690
Authors: Angeliki Asimaki; Harikrishna Tandri; Elizabeth R Duffy; Jeffrey R Winterfield; Shannon Mackey-Bojack; Maria M Picken; Leslie T Cooper; David J Wilber; Frank I Marcus; Cristina Basso; Gaetano Thiene; Adalena Tsatsopoulou; Nikos Protonotarios; William G Stevenson; William J McKenna; Shiva Gautam; Daniel G Remick; Hugh Calkins; Jeffrey E Saffitz Journal: Circ Arrhythm Electrophysiol Date: 2011-08-22
Authors: F I Marcus; G H Fontaine; G Guiraudon; R Frank; J L Laurenceau; C Malergue; Y Grosgogeat Journal: Circulation Date: 1982-02 Impact factor: 29.690
Authors: L Daliento; P Turrini; A Nava; G Rizzoli; A Angelini; G Buja; R Scognamiglio; G Thiene Journal: J Am Coll Cardiol Date: 1995-03-01 Impact factor: 24.094
Authors: Marina Cerrone; Jerome Montnach; Xianming Lin; Yan-Ting Zhao; Mingliang Zhang; Esperanza Agullo-Pascual; Alejandra Leo-Macias; Francisco J Alvarado; Igor Dolgalev; Thomas V Karathanos; Kabir Malkani; Chantal J M Van Opbergen; Joanne J A van Bavel; Hua-Qian Yang; Carolina Vasquez; David Tester; Steven Fowler; Fengxia Liang; Eli Rothenberg; Adriana Heguy; Gregory E Morley; William A Coetzee; Natalia A Trayanova; Michael J Ackerman; Toon A B van Veen; Hector H Valdivia; Mario Delmar Journal: Nat Commun Date: 2017-07-24 Impact factor: 14.919
Authors: Robyn J Hylind; Stephanie F Chandler; Virginie Beausejour Ladouceur; Shelina M Jamal; Mark E Alexander; Douglas Y Mah; Emily A Phaneuf; Elizabeth S DeWitt; Vassilios J Bezzerides; Dominic J Abrams Journal: J Am Heart Assoc Date: 2020-05-11 Impact factor: 5.501
Authors: Juha H Vähätalo; Lauri T A Holmström; Katri Pylkäs; Sini Skarp; Katja Porvari; Lasse Pakanen; Kari S Kaikkonen; Juha S Perkiömäki; Risto Kerkelä; Heikki V Huikuri; Robert J Myerburg; M Juhani Junttila Journal: Front Cardiovasc Med Date: 2022-01-11
Authors: Eric D Carruth; Dominik Beer; Amro Alsaid; Marci L B Schwartz; Megan McMinn; Melissa A Kelly; Adam H Buchanan; Christopher D Nevius; Hugh Calkins; Cynthia A James; Brittney Murray; Crystal Tichnell; Martin E Matsumura; H Lester Kirchner; Brandon K Fornwalt; Amy C Sturm; Christopher M Haggerty Journal: Circ Genom Precis Med Date: 2021-03-08
Authors: Viraj Patel; Babken Asatryan; Bhurint Siripanthong; Patricia B Munroe; Anjali Tiku-Owens; Luis R Lopes; Mohammed Y Khanji; Alexandros Protonotarios; Pasquale Santangeli; Daniele Muser; Francis E Marchlinski; Peter A Brady; C Anwar A Chahal Journal: Int J Mol Sci Date: 2020-09-10 Impact factor: 5.923
Authors: Jirko Kühnisch; Sabine Klaassen; Franziska Seidel; Manuel Holtgrewe; Nadya Al-Wakeel-Marquard; Bernd Opgen-Rhein; Josephine Dartsch; Christopher Herbst; Dieter Beule; Thomas Pickardt; Karin Klingel; Daniel Messroghli; Felix Berger; Stephan Schubert Journal: Circ Genom Precis Med Date: 2021-07-02
Authors: Maully J Shah; Michael J Silka; Jennifer N Avari Silva; Seshadri Balaji; Cheyenne M Beach; Monica N Benjamin; Charles I Berul; Bryan Cannon; Frank Cecchin; Mitchell I Cohen; Aarti S Dalal; Brynn E Dechert; Anne Foster; Roman Gebauer; M Cecilia Gonzalez Corcia; Prince J Kannankeril; Peter P Karpawich; Jeffery J Kim; Mani Ram Krishna; Peter Kubuš; Martin J LaPage; Douglas Y Mah; Lindsey Malloy-Walton; Aya Miyazaki; Kara S Motonaga; Mary C Niu; Melissa Olen; Thomas Paul; Eric Rosenthal; Elizabeth V Saarel; Massimo Stefano Silvetti; Elizabeth A Stephenson; Reina B Tan; John Triedman; Nicholas H Von Bergen; Philip L Wackel Journal: Indian Pacing Electrophysiol J Date: 2021-07-29